Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.

NCT06754540 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Relapse

Interventions

DRUG: Azacitidine (AZA)

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine